Widely used:Recently Viewed
Clear All₹403.15
₹-17.45
(-4.15%)
As on 25-Apr-2025 10:44IST
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹3,851 Cr
P/E Ratio
25.48
P/B Ratio
6.91
Industry P/E
52.15
Debt to Equity
0
ROE
28.92 %
ROCE
39.7 %
Div. Yield
1.07 %
Book Value
60.79
EPS
16.49
CFO
₹829.27 Cr
EBITDA
₹981.63 Cr
Net Profit
₹447.37 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| -22.90 | -3.15 | -11.86 | 50.60 | 80.15 | 58.23 | 22.51 |
|
BSE Healthcare
| -7.31 | -1.07 | -0.81 | 19.81 | 19.27 | 22.11 | 9.77 |
|
BSE Small Cap
| -12.77 | -0.12 | -4.61 | 2.00 | 17.79 | 35.06 | 15.82 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Indraprastha Med
| 192.94 | 107.52 | 9.13 | 32.78 | 41.46 | 0.38 | -39.32 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 552.80 | 7,911.13 | 135.67 | 6.56 | |
| 1,460.30 | 9,827.04 | 50.68 | 15.84 | |
| 5,510.00 | 6,125.97 | 29.68 | 22.17 | |
| 485.15 | 4,824.94 | 37.06 | 14.41 |
No Review & Analysis are available.
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and... cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India. Read more
Incorporated
1988
Chairman
--
Managing Director
Shivakumar Pattabhiraman
Group
Apollo Hospitals
Headquarters
New Delhi, Delhi
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Indraprastha Medical Corporation Ltd stood at ₹ 806 Cr as on 31-Dec-24
The share price of Indraprastha Medical Corporation Ltd is ₹403.15 (NSE) and ₹404.35 (BSE) as of 25-Apr-2025 10:44 IST. Indraprastha Medical Corporation Ltd has given a return of 80.15% in the last 3 years.
Indraprastha Medical Corporation Ltd has a market capitalisation of ₹ 3,851 Cr as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Indraprastha Medical Corporation Ltd is 6.91 times as on 24-Apr-2025, a 8% discount to its peers’ median range of 7.50 times.
The P/E ratio of Indraprastha Medical Corporation Ltd is 25.48 times as on 24-Apr-2025, a 51% discount to its peers’ median range of 52.15 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Indraprastha Medical Corporation Ltd and enter the required number of quantities and click on buy to purchase the shares of Indraprastha Medical Corporation Ltd.
Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of sugar, genomic medicine, elder care, anesthesiology, bariatric and metabolic surgery, bone marrow transplant, dental and cosmetic clinic, dermatology, dietetics and clinical nutrition, vascular and endovascular surgery, endocrinology, ENT, fetal medicine, general and laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, neonatology, nephrology, nuclear medicine, ophthalmology, pediatric sciences, urology, and plastic surgery, as well as pediatric urology and surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology and radio diagnosis, respiratory, rheumatology, spine surgery, urology and andrology, cardiology, oncology, emergency, gastroenterology, neuroscience, critical care, orthopedics, robotic surgery, and transplant, as well as laboratory services, internal medicine, preventive health, and sleep medicine. The company was founded in 1983 and is based in New Delhi, India.
The promoters of Indraprastha Medical Corporation Ltd are President Of India and Apollo Hospitals Enterprise Limited. They collectively own 48.02 per cent of the total equity. The chairman of the company is
There is no promoter pledging in Indraprastha Medical Corporation Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,638
|
|
|
8,277
|
|
|
6,106
|
|
|
4,889
|
| Indraprastha Medical Corporation Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
30.16
|
|
Operating margin(%)
|
14.04
|
|
Net Margin(%)
|
11.13
|
|
Dividend yield(%)
|
1.07
|
Yes, TTM profit after tax of Indraprastha Medical Corporation Ltd was ₹151 Cr.
